Clinical trial

Prevention of Cystic Fibrosis Diabetes

NCT00967798

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2010-05-01

PhasePHASE3

Study timeline

Study start (unknown)2010-05-01Date precision: month

Registry last updated2018-06-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cystic Fibrosisunresolved

Prediabetesunresolved

Interventions

SitagliptinDRUG · verified · RxNorm: sitagliptin

Sponsors & collaborators

Emory Universitylead sponsor

Mapped research locations

AtlantaGeorgia, United States2 ColumbusOhio, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00967798 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.